Vanguard Group Inc Madrigal Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,668,806 shares of MDGL stock, worth $394 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,668,806
Previous 1,574,742 5.97%
Holding current value
$394 Million
Previous $364 Million 22.31%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$171.37 - $283.23 $16.1 Million - $26.6 Million
94,064 Added 5.97%
1,668,806 $446 Million
Q4 2023

Feb 14, 2024
BUY
$120.4 - $237.13 $169,041 - $332,930
1,404 Added 0.09%
1,574,742 $364 Million
Q3 2023

Nov 14, 2023
BUY
$146.04 - $225.78 $15.7 Million - $24.3 Million
107,816 Added 7.36%
1,573,338 $230 Million
Q2 2023

Aug 14, 2023
BUY
$203.88 - $312.0 $9.65 Million - $14.8 Million
47,349 Added 3.34%
1,465,522 $339 Million
Q1 2023

May 15, 2023
BUY
$231.06 - $307.08 $35.1 Million - $46.6 Million
151,798 Added 11.99%
1,418,173 $344 Million
Q4 2022

Feb 10, 2023
BUY
$58.39 - $296.54 $704,767 - $3.58 Million
12,070 Added 0.96%
1,266,375 $368 Million
Q3 2022

Nov 14, 2022
BUY
$60.57 - $79.51 $1.35 Million - $1.77 Million
22,322 Added 1.81%
1,254,305 $81.5 Million
Q2 2022

Aug 12, 2022
BUY
$58.04 - $100.2 $961,722 - $1.66 Million
16,570 Added 1.36%
1,231,983 $88.2 Million
Q1 2022

May 13, 2022
BUY
$55.89 - $101.89 $5.16 Million - $9.41 Million
92,352 Added 8.22%
1,215,413 $119 Million
Q4 2021

Feb 14, 2022
BUY
$72.34 - $95.09 $3.73 Million - $4.9 Million
51,531 Added 4.81%
1,123,061 $95.2 Million
Q3 2021

Nov 12, 2021
BUY
$78.35 - $105.02 $1.74 Million - $2.33 Million
22,220 Added 2.12%
1,071,530 $85.5 Million
Q2 2021

Aug 13, 2021
BUY
$97.2 - $137.59 $102 Million - $144 Million
1,049,310 New
1,049,310 $102 Million

Others Institutions Holding MDGL

# of Institutions
313
Shares Held
20M
Call Options Held
824K
Put Options Held
1.04M
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $4.04B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email